[Remote] Medical Science Liaison at Eli Lilly and Company

Czechia

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, HealthcareIndustries

Requirements

Deep content knowledge about specific disease states, Lilly and competitive compounds, and therapeutic area landscapes
Substantial research experience or clinical training to acquire and maintain the highest level of technical expertise
Continuous learning to stay updated on the latest research, products, disease states, and standard of care
Emotional intelligence, strategic thinking, and deep understanding of HCP needs
Ability to efficiently and precisely synthesize scientific and clinical knowledge to address SE/CE needs
Skills in analyzing customer data, planning, prioritizing, and executing strategic territory plans using analytical tools
Enterprise mindset for field execution, geo management, productivity, and compliant partnerships

Responsibilities

Provide scientific and clinical knowledge to leading researchers and practitioners (SEs/CEs) to address their needs, such as clinical care gaps and nuanced questions
Establish oneself as a reliable, trusted resource for unbiased, accurate, up-to-date medical and scientific information
Act as primary interface between Lilly Medical and SEs/CEs to deliver positive experiences, support evidence sharing, and address clinical care gaps for improved patient outcomes
Connect SEs/CEs with Lilly resources, internal business partners, and facilitate collaborative research opportunities
Partner with clinical development to support studies and investigators, including site identification, selection, recruitment, and delivery of disease state/scientific information
Analyze customer data, plan, and prioritize engagements with SEs/CEs via face-to-face and virtual interactions
Implement strategic territory plans, leverage analytical tools, and meet personal performance expectations
Recognize and communicate feedback and insights from SE/CE interactions to inform Lilly’s strategic direction for research, development, and commercialization
Facilitate scientific exchange between industry and scientific/clinical communities

Skills

Medical Science Liaison

Therapeutic Area Expertise

Scientific Exchange

Clinical Knowledge

Stakeholder Engagement

Disease State Management

Research Insights

Field Medical

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free